Quidel Co. (NASDAQ:QDEL) Director Jack W. Schuler sold 4,000 shares of Quidel stock in a transaction on Friday, January 5th. The stock was sold at an average price of $47.02, for a total value of $188,080.00. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink.
Quidel Co. (NASDAQ QDEL) traded down $0.72 during trading on Friday, reaching $44.92. The company had a trading volume of 123,940 shares, compared to its average volume of 353,828. The company has a current ratio of 6.28, a quick ratio of 5.68 and a debt-to-equity ratio of 0.70. The stock has a market cap of $1,500.00, a PE ratio of -280.75, a PEG ratio of 1.47 and a beta of 1.02. Quidel Co. has a 1 year low of $18.25 and a 1 year high of $49.47.
Quidel (NASDAQ:QDEL) last posted its quarterly earnings results on Wednesday, November 1st. The company reported ($0.16) EPS for the quarter, missing the consensus estimate of $0.05 by ($0.21). The business had revenue of $50.89 million during the quarter, compared to analysts’ expectations of $50.47 million. Quidel had a negative net margin of 2.33% and a negative return on equity of 2.36%. The firm’s quarterly revenue was up 3.1% compared to the same quarter last year. During the same quarter last year, the firm earned $0.10 EPS. equities research analysts predict that Quidel Co. will post -0.23 EPS for the current fiscal year.
QDEL has been the subject of several research reports. Zacks Investment Research downgraded Quidel from a “hold” rating to a “strong sell” rating in a research note on Thursday, December 28th. Barclays lifted their price objective on Quidel from $50.00 to $60.00 and gave the stock an “overweight” rating in a research report on Monday, January 22nd. CL King upgraded Quidel from a “neutral” rating to a “buy” rating and set a $52.00 price objective for the company in a research report on Thursday, January 4th. Canaccord Genuity reiterated a “buy” rating and set a $48.00 price objective on shares of Quidel in a research report on Wednesday, October 25th. Finally, Piper Jaffray Companies reiterated a “buy” rating and set a $50.00 price objective on shares of Quidel in a research report on Thursday, December 14th. One analyst has rated the stock with a sell rating, one has issued a hold rating and six have assigned a buy rating to the company’s stock. The stock presently has a consensus rating of “Buy” and a consensus target price of $53.50.
Institutional investors and hedge funds have recently bought and sold shares of the business. Vanguard Group Inc. lifted its stake in shares of Quidel by 3.2% in the 2nd quarter. Vanguard Group Inc. now owns 2,195,101 shares of the company’s stock valued at $59,575,000 after purchasing an additional 68,549 shares in the last quarter. Macquarie Group Ltd. lifted its stake in shares of Quidel by 8.1% in the 2nd quarter. Macquarie Group Ltd. now owns 1,292,492 shares of the company’s stock valued at $35,078,000 after purchasing an additional 96,565 shares in the last quarter. New York State Common Retirement Fund lifted its stake in shares of Quidel by 0.7% in the 3rd quarter. New York State Common Retirement Fund now owns 899,390 shares of the company’s stock valued at $39,447,000 after purchasing an additional 6,635 shares in the last quarter. Fred Alger Management Inc. lifted its stake in shares of Quidel by 0.4% in the 2nd quarter. Fred Alger Management Inc. now owns 672,880 shares of the company’s stock valued at $18,262,000 after purchasing an additional 2,757 shares in the last quarter. Finally, Renaissance Technologies LLC lifted its stake in shares of Quidel by 27.6% in the 2nd quarter. Renaissance Technologies LLC now owns 612,487 shares of the company’s stock valued at $16,623,000 after purchasing an additional 132,587 shares in the last quarter. Institutional investors own 92.19% of the company’s stock.
TRADEMARK VIOLATION WARNING: “Jack W. Schuler Sells 4,000 Shares of Quidel Co. (QDEL) Stock” was originally posted by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are accessing this report on another site, it was illegally stolen and republished in violation of United States & international trademark & copyright law. The legal version of this report can be read at https://www.dispatchtribunal.com/2018/02/03/insider-selling-quidel-co-qdel-director-sells-188080-00-in-stock.html.
Quidel Corporation is engaged in the development, manufacturing and marketing of diagnostic testing solutions. These diagnostic testing solutions are separated into four product categories: immunoassays, molecular assays, virology and specialty products. The Company sells its products directly to end users and distributors, in each case, for professional use in physician offices, hospitals, clinical laboratories, reference laboratories, universities, retail clinics, pharmacies and wellness screening centers.
Receive News & Ratings for Quidel Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Quidel and related companies with MarketBeat.com's FREE daily email newsletter.